Skip to content

XC11 ICE System

by Yorlabs, Inc.

510(k) K250955

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK250955 Date22 Oct 2025ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
XC11 ICE System, USA
510(k) Number
FDA Product Code
OBJ
Device Class
Class II
Regulation
21 CFR Part 870.1200
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The XC11 ICE System is an intravascular ultrasound catheter designed for intracardiac echocardiography (ICE) imaging. It provides real-time visualization of cardiac structures and blood flow during interventional procedures, enabling precise guidance for catheter-based interventions in the cardiovascular system.

This system is intended for single-operator use and features simplified controls tailored for ICE-guided procedures. Supplied as a reusable device, it requires appropriate sterilization and maintenance per manufacturer instructions. The XC11 is classified as a Class II medical device under FDA regulations (510(k) clearance, K250955) and adheres to special controls for intravascular ultrasound catheters (product code OBJ).

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of procedures is the XC11 ICE System primarily used to guide, and why is real-time imaging important in these settings?

    The XC11 ICE System is designed for intracardiac echocardiography (ICE) imaging, which provides real-time visualization of cardiac structures and blood flow during catheter-based interventions. This is critical in procedures like structural heart interventions (e.g., mitral valve repairs, atrial septal defect closures) or electrophysiology studies, where precise guidance is essential to ensure accuracy, minimize risks, and avoid complications.

  • Is the XC11 ICE System intended for single-use or reusable applications, and what maintenance is required?

    The XC11 ICE System is supplied as a reusable device, meaning it is designed for multiple uses after proper sterilization and maintenance. Users must follow the manufacturer’s instructions for cleaning, sterilization, and upkeep to ensure safety, performance, and longevity. This includes adhering to protocols for disinfection and storage to prevent contamination or damage.

  • How do I determine which model or size of the XC11 ICE System is appropriate for my patient or procedure?

    The XC11 ICE System comes in multiple configurations, as indicated by the extensive list of registration numbers in the FDA database. While the exact sizing details (e.g., catheter diameter, length, or tip shape) are not provided here, these variations are typically tailored to accommodate different patient anatomies, procedural needs, or access routes (e.g., femoral, jugular). Consulting the manufacturer’s product catalog or technical specifications will help match the correct model to your clinical requirements.

  • What regulatory pathway was followed for the FDA clearance of the XC11 ICE System, and how does this affect its use?

    The XC11 ICE System received FDA clearance through a 510(k) Traditional Review process, classified as Substantially Equivalent (SESE) under the Cardiovascular (CV) Advisory Committee. This means the device was determined to be as safe and effective as a legally marketed predicate device (an intravascular ultrasound catheter) and adheres to special controls for its product code (OBJ). Clinicians may rely on this clearance to confirm the device meets FDA standards for intravascular ultrasound applications in intracardiac procedures.

  • How should the XC11 ICE System be stored to maintain its performance and sterility between uses?

    Since the XC11 is reusable, proper storage is critical to preserve its functionality and sterility. The manufacturer’s instructions outline specific storage conditions, likely including protection from moisture, extreme temperatures, and physical damage. Typically, this involves storing the device in a clean, dry environment (e.g., a sealed pouch or dedicated storage case) and following any additional guidelines for shelf life or reprocessing cycles to ensure reliability for subsequent procedures.